Top

Journal of Cardiothoracic Surgery

Published in:

Open Access 01-12-2015 | Research article

Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass

Authors: Gábor Veres, Tamás Radovits, Béla Merkely, Matthias Karck, Gábor Szabó

Published in: Journal of Cardiothoracic Surgery | Issue 1/2015

Abstract

Backgrounds

On the basis of Custodiol preservation and cardioplegic solution a novel cardioplegic solution was developed to improve the postischemic cardiac and endothelial function. In this study, we investigated whether its reduced cytotoxicity and its ability to reduce reactive oxygen species generation during hypoxic condition have beneficial effects in a clinically relevant canine model of CPB.

Methods

12 dogs underwent cardiopulmonary bypass with 60 minutes of hypothermic cardiac arrest. Dogs were divided into 2 groups: Custodiol (n = 6) and Custodiol-N (n = 6) (addition of L-arginin, N-α-acetyl-L-histidine and iron-chelators: deferoxamine and LK-614). Left ventricular hemodynamic variables were measured by a combined pressure-volume conductance catheter at baseline and after 60 minutes of reperfusion. Coronary blood flow, myocardial ATP content, plasma nitrate/nitrite and plasma myeloperoxidase levels were also determined.

Results

The use of Custodiol-N cardioplegic solution improved coronary blood flow (58 ± 7 ml/min vs. 26 ± 3 ml/min) and effectively prevented cardiac dysfunction after cardiac arrest. In addition, the myocardial ATP content (12,8 ± 1,0 μmol/g dry weight vs. 9,5 ± 1,5 μmol/g dry weight) and plasma nitrite (1,1 ± 0,3 ng/ml vs. 0,5 ± 0,2 ng/ml) were significantly higher after application of the new cardioplegic solution. Furthermore, plasma myeloperoxidase level (3,4 ± 0,4 ng/ml vs. 4,3 ± 2,2 ng/ml) significantly decreased in Custodiol-N group.

Conclusions

The new HTK cardioplegic solution (Custodiol-N) improved myocardial and endothelial function after cardiopulmonary bypass with hypothermic cardiac arrest. The observed protective effects imply that the Custodiol-N could be the next generation cardioplegic solution in the protection against ischemia-reperfusion injury in cardiac surgery.

Yang Q, He GW. Effect of cardioplegic and organ preservation solutions and their components on coronary endothelium-derived relaxing factor. Ann Thorac Surg. 2005;80:757–67. Review.CrossRefPubMed

Careaga G, Salazar D, Tellez S, Sanchez O, Borrayo G, Argulero R. Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cadioplegic solution on the perioperative period in open heart surgery subjects. Arch Med Red. 2001;32:296–9.CrossRef

Robinson LA, Schwarz GD, Goddard DB, Fleming WH, Galbraith TA. Myocardial protection for acquired heart disease surgery: results of a national survey. Ann Thorac Surg. 1995;59:361–72.CrossRefPubMed

Guru V, Omura J, Alghamdi AA, Weisel R, Fremes SE. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation. 2006;114:I331–8.CrossRefPubMed

Braathen B, Jeppsson A, Scherstén H, Hagen OM, Vengen Ø, Rexius H, et al. One single dose of histidine-tryptophan-ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: a prospective randomized study. J Thorac Cardiovasc Surg. 2011;141:995–1001.CrossRefPubMed

Scrascia G, Guida P, Rotunno C, De Palo M, Mastro F, Pignatelli A, et al. Myocardial protection during aortic surgery: comparison between Bretschneider-HTK and cold blood cardioplegia. Perfusion. 2011;26:427–33.CrossRefPubMed

Rauen U, Kerkweg U, DeGroot H. Iron-dependent vs. iron-independent cold-induced injury to cultured rat hepatocytes: a comparative study in physiological media and organ preservation solutions. Cryobiology. 2007;54:77–86.CrossRefPubMed

Rauen U, Klempt S, de Groot H. Histidine-induced injury to cultured liver cells, effects of histidine derivatives and of iron chelators. Cell Mol Life Sci. 2007;64:192–205.CrossRefPubMed

Pizanis N, Gillner S, Kamler M, de Groot H, Jakob H, Rauen U. Cold-induced injury to lung epithelial cells can be inhibited by iron chelators - implications for lung preservation. Eur J Cardiothorac Surg. 2011;40:948–55.PubMed

10.

Wu K, Türk TR, Rauen U, Su S, Feldkamp T, de Groot H, et al. Prolonged cold storage using a new histidine-tryptophan-ketoglutarate-based preservation solution in isogeneic cardiac mouse grafts. Eur Heart J. 2011;32:509–16.CrossRefPubMed

11.

Pizanis N, Petrov A, Heckmann J, Wiswedel I, Wohlschläger J, de Groot H, et al. A new preservation solution for lung transplantation: Evaluation in a porcine transplantation model. J Heart Lung Transplant. 2012;31:310–7.CrossRefPubMed

12.

Bahde R, Palmes D, Gemsa O, Minin E, Stratmann U, de Groot H, et al. Attenuated cold storage injury of rat livers using a modified HTK solution. J Surg Res. 2008;146:49–56.CrossRefPubMed

13.

Radovits T, Lin LN, Zotkina J, Koch A, Rauen U, Köhler G, et al. Endothelial dysfunction after long-term cold storage in HTK organ preservation solutions: effects of iron chelators and N-alpha-acetyl-L-histidine. J Heart Lung Transplant. 2008;27:208–16.CrossRefPubMed

14.

Loganathan S, Radovits T, Hirschberg K, Korkmaz S, Koch A, Karck M, et al. Effects of Custodiol-N, a novel organ preservation solution, on ischemia/reperfusion injury. J Thorac Cardiovasc Surg. 2010;139:1048–56.CrossRefPubMed

15.

Wallace A, Lam HW, Nosé PS, Bellows W, Mangano DT. Changes in systolic and diastolic ventricular function with cold cardioplegic arrest in man. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Card Surg. 1994;9:497–502.PubMed

16.

Szabó G, Seres L, Soós P, Gorenflo M, Merkely B, Horkay F, et al. Tetrahydrobiopterin improves cardiac and pulmonary function after cardiopulmonary bypass. Eur J Cardiothorac Surg. 2011;40:695–700.PubMed

17.

Rauen U, de Groot U. New insights into the cellular and molecular mechanisms of cold storage injury. J Investig Med. 2004;52:299–309.CrossRefPubMed

18.

Petrat F, de Groot H, Sustmann R, Rauen U. The chelatable iron pool in living cells: a methodically defined quantity. Biol Chem. 2002;383:489–502.CrossRefPubMed

19.

Rauen U, Petrat F, Li T, De Groot H. Hypothermia injury/cold-induced apoptosis–evidence of an increase in chelatable iron causing oxidative injury in spite of low O2-/H2O2 formation. FASEB J. 2000;14:1953–64.CrossRefPubMed

20.

Soos P, Andrasi T, Buhmann V, Kohl B, Vahl C, Hagl S, et al. Myocardial protection after systemic application of L-arginine during reperfusion. J Cardiovasc Pharmacol. 2004;43:782–8.CrossRefPubMed

21.

Andrews DT, Sutherland J, Dawson P, Royse AG, Royse C. L-arginine cardioplegia reduces oxidative stress and preserves diastolic function in patients with low ejection fraction undergoing coronary artery surgery. Anaesth Intensive Care. 2012;40:99–106.CrossRefPubMed

22.

Schröder C, Heintz A, Pexa A, Rauen U, Deussen A. Preclinical evaluation of coronary vascular function after cardioplegia with HTK and different antioxidant additives. Eur J Cardiothorac Surg. 2007;31:821–6.CrossRefPubMed

23.

Kleinbongard P, Dejam A, Lauer T, Rassaf T, Schindler A, Picker O, et al. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med. 2003;35:790–6.CrossRefPubMed

24.

Loria V, Dato I, Graziani F, Biasucci LM. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm. 2008;2008:135625.CrossRefPubMedPubMedCentral

25.

Rauen U, Polzar B, Stephan H, Mannherz HG, de Groot H. Cold-induced apoptosis in cultured hepatocytes and liver endothelial cells: mediation by reactive oxygen species. FASEB J. 1999;13:155–68.PubMed

Title: Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass
Authors: Gábor Veres
Tamás Radovits
Béla Merkely
Matthias Karck
Gábor Szabó
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: Journal of Cardiothoracic Surgery / Issue 1/2015
Electronic ISSN: 1749-8090
DOI: https://doi.org/10.1186/s13019-015-0226-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass

Abstract

Backgrounds

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Backgrounds

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2015

Effect of N-acetylcysteine and allopurinol combination to protect spinal cord ischemia/reperfusion injury induced by aortic cross-clamping in rat model

Full-root aortic valve replacement with stentless xenograft achieves superior regression of left ventricular hypertrophy compared to pericardial stented aortic valves

Early and midterm results of transapical and right axillary artery cannulation for acute aortic dissection

Video-assisted thoracoscpic muscle transposition for acute empyema

3D transesophageal echocardiography is a decision-making tool for the management of cardiogenic shock following a large postinfarction ventricular defect

Predicting the risk of death following coronary artery bypass graft made simple: a retrospective study using the American College of Surgeons National Surgical Quality Improvement Program database